267 related articles for article (PubMed ID: 16471425)
1. Managing the microbiological quality of pharmaceutical excipients.
Cundell AM
PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
[TBL] [Abstract][Full Text] [Related]
2. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
Hasanain F; Guenther K; Mullett WM; Craven E
PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
[TBL] [Abstract][Full Text] [Related]
3. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
Patel KT; Chotal NP
Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
[TBL] [Abstract][Full Text] [Related]
4. Microbial identification strategies in the pharmaceutical industry.
Cundell AM
PDA J Pharm Sci Technol; 2006; 60(2):111-23. PubMed ID: 16696194
[TBL] [Abstract][Full Text] [Related]
5. A practical discussion of risk management for manufacturing of pharmaceutical products.
Mollah AH; Baseman HS; Long M; Rathore AS
PDA J Pharm Sci Technol; 2014; 68(3):271-80. PubMed ID: 25188348
[TBL] [Abstract][Full Text] [Related]
6. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
Chang LC; Kang JJ; Gau CS
Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
[TBL] [Abstract][Full Text] [Related]
7. Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined.
Hertrampf A; Müller H; Menezes JC; Herdling T
Int J Pharm; 2015 Nov; 495(1):447-458. PubMed ID: 26342249
[TBL] [Abstract][Full Text] [Related]
8. Bacterial endotoxin requirements for dry powder inhalants and their excipients: are they critical quality attributes?
Cundell AM
PDA J Pharm Sci Technol; 2014; 68(5):386-93. PubMed ID: 25336414
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances.
Humfrey CD
Toxicol Sci; 2007 Nov; 100(1):24-8. PubMed ID: 17656486
[TBL] [Abstract][Full Text] [Related]
10. Approaches to Quality Risk Management When Using Single-Use Systems in the Manufacture of Biologics.
Ishii-Watabe A; Hirose A; Katori N; Hashii N; Arai S; Awatsu H; Eiza A; Hara Y; Hattori H; Inoue T; Isono T; Iwakura M; Kajihara D; Kasahara N; Matsuda H; Murakami S; Nakagawa T; Okumura T; Omasa T; Takuma S; Terashima I; Tsukahara M; Tsutsui M; Yano T; Kawasaki N
AAPS PharmSciTech; 2015 Oct; 16(5):993-1001. PubMed ID: 26288941
[TBL] [Abstract][Full Text] [Related]
11. [Microbiological in-process control in drug manufacture].
Seyfarth VH
Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
Eissa ME
PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
[TBL] [Abstract][Full Text] [Related]
13. Raw material considerations.
Lubiniecki AS; Shadle PJ
Dev Biol Stand; 1997; 91():65-72. PubMed ID: 9413684
[TBL] [Abstract][Full Text] [Related]
14. A PAT-based qualification of pharmaceutical excipients produced by batch or continuous processing.
Hertrampf A; Müller H; Menezes JC; Herdling T
J Pharm Biomed Anal; 2015 Oct; 114():208-15. PubMed ID: 26072012
[TBL] [Abstract][Full Text] [Related]
15. Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
Rolke R; Ramnarine E; Vinther A; Sawant A
PDA J Pharm Sci Technol; 2020; 74(2):286-288. PubMed ID: 32179712
[TBL] [Abstract][Full Text] [Related]
16. An Elemental Impurities Excipient Database: A Viable Tool for ICH Q3D Drug Product Risk Assessment.
Boetzel R; Ceszlak A; Day C; Drumm P; Gil Bejar J; Glennon J; Harris L; Heghes CI; Horga R; Jacobs PL; Keurentjes WJTM; King F; Lee CW; Lewen N; Marchant CA; Maris FA; Nye W; Powell S; Rockstroh H; Rutter L; Schweitzer M; Shannon E; Smallshaw L; Teasdale A; Thompson S; Wilkinson D
J Pharm Sci; 2018 Sep; 107(9):2335-2340. PubMed ID: 29679706
[TBL] [Abstract][Full Text] [Related]
17. A perspective on testing of existing pharmaceutical excipients for genotoxic impurities.
Brusick DJ
Regul Toxicol Pharmacol; 2009 Nov; 55(2):200-4. PubMed ID: 19607870
[TBL] [Abstract][Full Text] [Related]
18. Organic solvents in the pharmaceutical industry.
Grodowska K; Parczewski A
Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
[TBL] [Abstract][Full Text] [Related]
19. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
20. Microbiological quality of pharmaceutical raw materials.
de la Rosa MC; Medina MR; Vivar C
Pharm Acta Helv; 1995 Sep; 70(3):227-32. PubMed ID: 7480068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
